$4.51
0.030.67%
Pre-Market: 4:20 PM EDT
15 minutes delayed
Comments
Loading...
Orgenesis (NASDAQ:ORGS) Stock Quotes, Forecast and News Summary
Orgenesis Stock (NASDAQ: ORGS) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Orgenesis (ORGS) stock?
You can purchase shares of Orgenesis (NASDAQ:ORGS) through any online brokerage.
Who are Orgenesis (ORGS) competitors?
Other companies in Orgenesis’s space includes: Vincerx Pharma (NASDAQ:VINC), Aligos Therapeutics (NASDAQ:ALGS), Bolt Biotherapeutics (NASDAQ:BOLT), Gritstone Bio (NASDAQ:GRTS) and Geovax Labs (NASDAQ:GOVX).
What is the forecast, or price target, for Orgenesis (ORGS) stock?
Orgenesis has a consensus price target of $6.00.
What is the current price for Orgenesis (ORGS)?
The stock price for Orgenesis (NASDAQ: ORGS) is $4.51 last updated October 1, 2024 at 4:20 PM EDT.
Does Orgenesis (ORGS) pay a dividend?
There are no upcoming dividends for Orgenesis.
When is Orgenesis (NASDAQ:ORGS) reporting earnings?
Orgenesis’s Q3 earnings are confirmed for Monday, November 11, 2024.
Is Orgenesis (ORGS) going to split?
There is no upcoming split for Orgenesis.
What sector and industry does Orgenesis (ORGS) operate in?
Orgenesis is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.